AS
Anand Subramanian Iyer
About Anand Subramanian Iyer
Data last updated:
Anand Subramanian Iyer is a Director at Mahaveer Medi-Sales Private Limited (since 2021), Director at Aryan Wellness Private Limited (since 2022) and Director at Akp Healthcare Private Limited (since 2021), and holds 4 more current directorships. The companies operate in Pharma, Financial Services and BFSI. The 5 current companies with reported revenue have a combined latest revenue of ₹1,620 Cr; the largest is Mahaveer Medi-Sales Private Limited at ₹1,045 Cr (FY 2025). Earlier, Anand Subramanian Iyer was a Director at Dhanayu Finance Private Limited (2024–2025) and Director at Reenav Pharma Private Limited (2022–2024) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mahaveer Medi-Sales Private Limited U51103MH2016PTC442989 | Director | 25 Nov 2021 | 2016 | ₹1,045 Cr (FY 2025) | Active |
 Aryan Wellness Private Limited U51909HR2017PTC071447 | Director | 24 Jan 2022 | 2017 | ₹292 Cr (FY 2025) | Active |
| Akp Healthcare Private Limited U24304KA2017PTC106747 | Director | 25 Nov 2021 | 2017 | ₹279 Cr (FY 2025) | Active |
| J. A. Credit Consultants Private Limited U74140MH2003PTC141504 | Director | 28 Jul 2003 | 2003 | ₹4.22 Cr (FY 2025) | Active |
| Enron Securities Private Limited U67120MH1994PTC082382 | Director | 27 Jul 2009 | 1994 | ₹18.2 Lakh (FY 2024) | Active |
| Humaatrix Business Solutions Llp ACT-6472 | Designated Partner | 19 Dec 2025 | 2025 | Active | |
| Callstreet Solutions India Private Limited U72900MH2008PTC177311 | Director | 03 Jan 2008 | 2008 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Dhanayu Finance Private Limited U64990KA2024PTC192617 | Director | 31 Aug 2024 | 2024 | ₹45.4 Lakh (FY 2025) | Active |
| Reenav Pharma Private Limited U74999MH2018PTC308208 | Director | 24 Jan 2022 | 2018 | ₹2.21 Cr (FY 2025) | Active |
| D. C. Agencies Private Limited U74999DL2016PTC304376 | Additional Director | 25 Nov 2021 | 2016 | ₹284 Cr (FY 2024) | Active |
| Muthu Pharma Private Limited U51909MH2016PTC449216 | Additional Director | 25 Nov 2021 | 2016 | ₹235 Cr (FY 2022) | Active |
 Eastern Agencies Healthcare Private Limited U74999MH2013PTC248123 | Additional Director | 25 Nov 2021 | 2013 | ₹324 Cr (FY 2025) | Active |
 Ayro Retail Solutions Private Limited U74999MH2017PTC441194 | Additional Director | 25 Nov 2021 | 2017 | ₹12.24 Cr (FY 2023) | Active |
| Aushad Pharma Distributors Private Limited U24290KA2018PTC119413 | Additional Director | 24 Jan 2022 | 2018 | ₹116 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anand Subramanian Iyer
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anand Subramanian Iyer
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anand Subramanian Iyer
Anand Subramanian Iyer currently holds 7 directorships: Mahaveer Medi-Sales Private Limited (Director, since 25 Nov 2021, revenue ₹1,045 Cr (FY 2025)); Aryan Wellness Private Limited (Director, since 24 Jan 2022, revenue ₹292 Cr (FY 2025)); Akp Healthcare Private Limited (Director, since 25 Nov 2021, revenue ₹279 Cr (FY 2025)); J. A. Credit Consultants Private Limited (Director, since 28 Jul 2003, revenue ₹4.22 Cr (FY 2025)); Enron Securities Private Limited (Director, since 27 Jul 2009, revenue ₹18.2 Lakh (FY 2024)); and 2 more.
Anand Subramanian Iyer was first appointed on 28 Jul 2003 as Director at J. A. Credit Consultants Private Limited. The most recent appointment on record is 19 Dec 2025 at Humaatrix Business Solutions Llp.
The 5 current companies of Anand Subramanian Iyer that report revenue have a combined latest revenue of ₹1,620 Cr: Mahaveer Medi-Sales Private Limited ₹1,045 Cr (FY 2025); Aryan Wellness Private Limited ₹292 Cr (FY 2025); Akp Healthcare Private Limited ₹279 Cr (FY 2025); J. A. Credit Consultants Private Limited ₹4.22 Cr (FY 2025); Enron Securities Private Limited ₹18.2 Lakh (FY 2024).
Anand Subramanian Iyer held 7 earlier board appointments: Dhanayu Finance Private Limited (Director, 31 Aug 2024 to 08 Dec 2025); Reenav Pharma Private Limited (Director, 24 Jan 2022 to 31 Dec 2024); D. C. Agencies Private Limited (Additional Director, 25 Nov 2021 to 25 Jan 2022); Muthu Pharma Private Limited (Additional Director, 25 Nov 2021 to 25 Jan 2022); Eastern Agencies Healthcare Private Limited (Additional Director, 25 Nov 2021 to 25 Jan 2022); and 2 more.
The current boards of Anand Subramanian Iyer's companies include Ashish Arora (Mahaveer Medi-Sales Private Limited), Bherumal Jain (Mahaveer Medi-Sales Private Limited), Kalpana Srinivasan (Mahaveer Medi-Sales Private Limited), Nirmala Jain (Mahaveer Medi-Sales Private Limited), Rajaganesan Rajbalaji (Mahaveer Medi-Sales Private Limited), Uday Patel Kadam (Mahaveer Medi-Sales Private Limited), among others.